Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

PUMA BIOTECHNOLOGY INC. (PBYI)

NASDAQ

$9.56

$+0.14

(+1.54%)

Previous Close: ⁦$9.41⁩

Market Closed

PUMA BIOTECHNOLOGY INC. (PBYI) Live Price Chart

Last updated: ⁦2026-09-05 12:46:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

PUMA BIOTECHNOLOGY INC. (PBYI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $9.56, with a market capitalisation of $500.20M and a P/E ratio of 18.18. Over the past 52 weeks, its price has ranged from $4.30 to $9.74. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$500.20M
Open	$9.44
Day's High	$279.37
Day's Low	$1.60
Previous Close	$9.41
Volume	142.16K
Average Volume	--
P/E Ratio	18.18
52-Week High	$9.74
52-Week Low	$4.30
Dividend Yield	--
Earnings Date	--

PUMA BIOTECHNOLOGY INC. (PBYI) Latest Closing Stock Price

PUMA BIOTECHNOLOGY INC. (PBYI) last closed at $9.41 as of 2026-09-04 23:31:00, unchanged from the previous close of $9.41.

During the latest regular trading session, PBYI traded between $1.60 and $279.37, with a volume of 142.16K shares. The closing price was near the lower end and near the upper end of its 52-week range.

PUMA BIOTECHNOLOGY INC. (PBYI) 7-Day Stock Price Change

Over the past seven days, PUMA BIOTECHNOLOGY INC. (PBYI) moved from $9.02 to $9.56, representing a gain of 5.98% ($0.54).

The stock traded between $9.31 and $9.62 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 283.02 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

PBYI 52-Week Price Position

Position in Range: 96.8%

52W Low$4.30

52W High$9.74

PBYI is currently trading at $9.56, placing it 96.8% of the way from its 52-week low of $4.30 to its 52-week high of $9.74. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is PUMA BIOTECHNOLOGY INC. (PBYI)?

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

PUMA BIOTECHNOLOGY INC. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	179
Exchange	NASDAQ
Company Website	https://www.pumabiotechnology.com

How to Buy PUMA BIOTECHNOLOGY INC. (PBYI) Stock on MEXC

Eligible investors can buy real shares of PUMA BIOTECHNOLOGY INC. (PBYI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PBYI and Place Your Order

Open the RealStocks trading page and search for PBYI. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is PUMA BIOTECHNOLOGY INC. (PBYI) share price today?

PUMA BIOTECHNOLOGY INC. (PBYI) is currently trading at $ 9.56, up 1.58% ($0.15) from the previous close of $ 9.41. Intraday prices update in real time during regular trading hours.

2.Is PBYI stock going up or down today?

As of 2026-09-04 23:31:00, PBYI is trading at $ 9.56, up 1.58% ($0.15) from its previous close of $ 9.41. The stock has traded between $ 1.60 and $ 279.37 during today’s regular session. Past price movements do not guarantee future results.

3.What is PBYI pre-market price?

As of 2026-09-04 23:31:00, PBYI is trading at $ 9.56 in pre-market trading, up 1.58% ($0.15) from the previous close of $ 9.41. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PBYI after-hours price?

As of 2026-09-04 23:31:00, PBYI is trading at $ 9.56 in after-hours trading, up 1.59% ($0.15) from the regular-session close of $ 9.41. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is PBYI stock trading now?

PBYI trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PBYI sit relative to its 52-week high and low?

Over the past 52 weeks, PBYI has traded between a low of $ 4.30 and a high of $ 9.74. At $ 9.56, the stock is positioned 96.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is PUMA BIOTECHNOLOGY INC. in?

PUMA BIOTECHNOLOGY INC. (PBYI) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is PUMA BIOTECHNOLOGY INC.'s market capitalisation and where is it listed?

PUMA BIOTECHNOLOGY INC. is listed on the NASDAQ exchange with a market capitalisation of $ 500.20M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PBYI valued in terms of P/E ratio and EPS?

PBYI trades at a P/E ratio of 18.18, based on trailing-twelve-month EPS of $ 0.52. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does PUMA BIOTECHNOLOGY INC. pay a dividend?

PUMA BIOTECHNOLOGY INC. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.